Clinical trials in Ljubljana – page 2

95 clinical trials in Ljubljana, Slovenia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SloveniaKlinicnaPreskusanja.si

Ljubljana at a glance

clinical trials

Research sites1

Quick filters

95 trials in Ljubljana

Open in trial search

Neurodevelopmental disorder

Recruiting

A Study of Gene Replacement Therapy for Children with CTNNB1 Syndrome Using Adeno-Associated Viral Vector Serotype 9 Containing the Human CTNNB1 Gene

InvestigationalNo placebo

A Study of Gene Replacement Therapy for Children with CTNNB1 Syndrome Using Adeno-Associated Viral Vector Serotype 9 Containing the Human CTNNB1 Gene

InvestigationalNo placebo

Slovenia

Participants:0–17 years
Substances:ADENO-ASSOCIATED VIRAL VECTOR SEROTYPE 9 CONTAINING THE HUMAN CTNNB1 GENE
Sponsor:Fundacija CTNNB1 Ustanova Za Raziskave Na Podrocju Genske Terapije

Contact Research Centre

Chronic inflammatory demyelinating polyradiculoneuropathy

Recruiting

A Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse

Investigational

A Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse

Investigational

Slovenia

Participants:18–64 years · 65+ years
Substances:Imeroprubart
Sponsor:Immunovant Sciences GmbH

Contact Research Centre

Colon cancer

Recruiting

A study evaluating the effects of intravenous lidocaine on pain control and recovery after colon cancer surgery

Registered drug

A study evaluating the effects of intravenous lidocaine on pain control and recovery after colon cancer surgery

Registered drug

Slovenia

Participants:18–64 years · 65+ years
Substances:Sodium Chloride
Sponsor:Institute Of Oncology Ljubljana

Contact Research Centre

IgA nephropathy

Recruiting

Study of Mezagitamab in Adults with Primary IgA Nephropathy (Berger's Disease) to Reduce Protein in Urine

Investigational

Study of Mezagitamab in Adults with Primary IgA Nephropathy (Berger's Disease) to Reduce Protein in Urine

Investigational

Slovenia

Participants:18–64 years · 65+ years
Substances:Mezagitamab
Sponsor:Takeda Development Center Americas Inc.

Contact Research Centre

Hypertension

Recruiting

Study of Dapagliflozin for Reducing Cardiovascular Events in Adults with High Blood Pressure

Registered drug

Study of Dapagliflozin for Reducing Cardiovascular Events in Adults with High Blood Pressure

Registered drug

Slovenia

Participants:18–64 years · 65+ years
Substances:Dapagliflozin
Sponsor:Universitaetsklinikum Schleswig-Holstein AöR

Contact Research Centre

Hormone-dependent prostate cancer

Recruiting

Study on the Effects of Darolutamide and Drug Combination for Patients with Metastatic Hormone-Naïve Prostate Cancer

Registered drugNo placebo

Study on the Effects of Darolutamide and Drug Combination for Patients with Metastatic Hormone-Naïve Prostate Cancer

Registered drugNo placebo

Slovenia

Participants:18–64 years · 65+ years
Substances:Abiraterone
Sponsor:European Organisation For Research And Treatment Of Cancer

Contact Research Centre

Anal incontinence

Recruiting

Study on ICEF15 for Treating Fecal Incontinence in Patients with Anal Sphincter Dysfunction

Registered drug

Study on ICEF15 for Treating Fecal Incontinence in Patients with Anal Sphincter Dysfunction

Registered drug

Slovenia

Participants:18–64 years · 65+ years
Substances:ICEF15
Sponsor:Innovacell GmbH

Contact Research Centre

Crohn's disease

Recruiting

Study on the Effectiveness and Safety of Vedolizumab and Upadacitinib in Adults with Moderate to Severe Crohn's Disease

Registered drug

Study on the Effectiveness and Safety of Vedolizumab and Upadacitinib in Adults with Moderate to Severe Crohn's Disease

Registered drug

Slovenia

Participants:18–64 years · 65+ years
Substances:Upadacitinib
Sponsor:Takeda Development Center Americas Inc.

Contact Research Centre

B-cell type acute leukaemia

Recruiting

Study on Pegaspargase and Rituximab for Treating Children with Acute Lymphoblastic Leukemia

Registered drugNo placebo

Study on Pegaspargase and Rituximab for Treating Children with Acute Lymphoblastic Leukemia

Registered drugNo placebo

Slovenia

Participants:0–17 years
Substances:Pegaspargase
Sponsor:Semmelweis University

Contact Research Centre

Neonatal alloimmune thrombocytopenia

Recruiting

Study of Nipocalimab or IVIG for Pregnant Women at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Registered drugNo placebo

Study of Nipocalimab or IVIG for Pregnant Women at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Registered drugNo placebo

Slovenia

Participants:18–64 years
Substances:Nipocalimab
Sponsor:Janssen Cilag International

Contact Research Centre

Acquired antithrombin III deficiency+1

Recruiting

Study on Antithrombin III Human for Patients with Heparin Resistance Undergoing Cardiac Surgery with Cardiopulmonary Bypass

Registered drug

Study on Antithrombin III Human for Patients with Heparin Resistance Undergoing Cardiac Surgery with Cardiopulmonary Bypass

Registered drug

Slovenia

Participants:18–64 years · 65+ years
Substances:Sodium Chloride
Sponsor:Octapharma AG

Contact Research Centre

Endometrial cancer+5

Recruiting

Study for Patients with BRCA Mutated Ovarian, Breast, Pancreatic, Prostate, and Endometrial Cancers Continuing Olaparib Treatment

Registered drugNo placebo

Study for Patients with BRCA Mutated Ovarian, Breast, Pancreatic, Prostate, and Endometrial Cancers Continuing Olaparib Treatment

Registered drugNo placebo

Slovenia

Participants:18–64 years · 65+ years
Substances:Olaparib
Sponsor:AstraZeneca AB

Contact Research Centre

Other cities in Slovenia

The busiest research cities in the country

All 18 cities in Slovenia

Clinical research in Ljubljana

What the registry says about research in the country

01 Autoimmune Conditions

Innovative research focusing on Sjögren's Syndrome and inflammatory bowel conditions, including studies evaluating novel therapeutic approaches for Crohn's Disease and Ulcerative Colitis.

Dazodalibep safety trials
Combination therapy assessments
Advanced treatment protocols

Multiple studies investigating long-term effectiveness and patient outcomes in chronic inflammatory conditions.

02 Cardiovascular Research

Comprehensive studies addressing cardiovascular disease and related conditions, including research on lipoprotein management and cardiac inflammation treatments.

Lipid-lowering therapies
Acute myocarditis treatment
Pulmonary embolism management

Focus on preventive measures and innovative therapeutic approaches for various cardiac conditions.

03 Oncology Studies

Advanced research in cancer treatment, including studies on breast cancer, melanoma, and various blood cancers.

Endocrine therapy optimization
Immunotherapy combinations
Leukemia treatment protocols

Emphasis on personalized treatment approaches and improved patient outcomes.

Back to Slovenia All countries